9 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Lower Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Active Bleeding

#LowerExtremity #Veins #Venous #Thrombosis
- Management and ... Superficial #Deep #VTE ... #DVT #Hematology ... #Anticoagulation ... #Algorithm
Upper Extremity Venous Thrombosis - Management and Anatomy

Deep - Superficial - Catheter Associated

#UpperExtremity #Veins #Venous #Thrombosis
- Management and ... Superficial #Deep #VTE ... #DVT #Hematology ... #Anticoagulation ... #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
catheter-related thrombosis ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management ... Algorithm #Anticoagulation ... #Breakthrough #Thrombosis ... #Algorithm #Extension ... #VTE #DVT #Hematology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation ... can result in thrombosis ... #management #algorithm ... #medications #table ... decisionaid #cardiology #hematology
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
or small-vessel thrombosis ... target to 3-4 • DOACs ... APS #diagnosis #management ... #anticoagulation ... #guidelines
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... Delivery • Stable ... suggest prophylactic anticoagulation ... e.g., <50%), ESC guidelines ... Serial TTE and close
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... Hydroxyurea + anticoagulation ... Thrombocythemia #ET #hematology ... #diagnosis #management ... #hematology